| 英文名称 |
中文名称 |
CAS |
|
Upadacitinib
|
乌帕替尼 |
1310726-60-3 |
|
3H-Imidazo[1,2-a]pyrrolo[2,3-e]pyrazine, 8-[(3R,4S)-4-ethyl-3-pyrrolidinyl]-, hydrochloride (1:2)
|
乌帕替尼N-1 |
2050038-84-9 |
|
Pipecuronium bromide
|
哌库溴铵 |
52212-02-9 |
|
Tadalafil
|
他达那非 |
171596-29-5 |
|
3-AZABICYCLO[3.3.0]OCTANE HYDROCHLORIDE
|
3-氮杂双环[3.3.0]辛烷盐酸盐 |
112626-50-3 |
|
Gliclazide
|
格列齐特 |
21187-98-4 |
|
Vecuronium bromide impurity C
|
维库溴铵杂质c |
73319-30-9 |
|
Vecuronium bromide impurity B
|
维库溴铵杂质B |
50587-95-6 |
|
Vecuronium bromide impurity F
|
维库溴铵杂质F |
73319-13-8 |
|
Rocuronium bromide intermediate 47
|
罗库溴铵杂质47 |
|
|
Rocuronium bromide intermediate
|
罗库溴铵杂质 |
159325-45-8 |
|
2-Methylindoline
|
2-甲基吲哚啉 |
6872-06-6 |
|
Cis-2,6-Dimethylmorpholine
|
顺式－2、6－二甲基吗啉 |
6485-55-8 |
|
Trans-2,6-Dimethylmorpholine
|
反式－2、6－二甲基吗啉 |
6485-45-6 |
|
α-Tropine
|
α-托品醇 |
120-29-6 |
|
Bis(2,2,6,6-tetramethyl-1-piperidinyloxy-4-yl) sebacate
|
双(2,2,6,6-四甲基-4-哌啶基)癸二酸酯氮氧自由基（UV-10） |
2516-92-9 |
|
|
β-托品醇 |
135-97-7 |
|
4-benzylidene-2,6-ditert-butylcyclohexa-2,5-dien-1-one
|
4-苯基亚甲基-2,6-二叔丁基-2,5-环己二烯-1-酮 |
7078-98-0 |
|
Rocuronium bromide impurity 65
|
罗库溴铵杂质65 |
103088-58-0 |
|
tadalafi
|
他达拉非 |
|
|
Rocuronium bromide Intermediate
|
罗库溴铵杂质 |
14935-81-0 |
|
Natamycin,PIMARICIN;Synogil;natacyn;
|
那他霉素 |
7681-93-8 |
|
Rocuronium impurity K
|
罗库溴铵杂质K |
|
|
Vecuronium bromide impurity
|
维库溴铵杂质 |
18668-29-6 |
|
2-Methoxy-5-nitrophenol sodium salt
|
5-硝基愈创木酚钠 |
67233-85-6 |
|
Benzeneazomalononitrile
|
苯基偶氮丙二腈 |
6017-21-6 |
|
3-Tropanone; 8-Methyl-8-azabicyclo[3.2.1]octan-3-one
|
托品酮 |
532-24-1 |
|
Granisetron Hydrochloride
|
盐酸格拉司琼 |
107007-99-8 |
|
2-methyl-1H-indole
|
2-甲基-1H-吲哚 |
95-20-5 |
|
Zorifertinib
|
佐利替尼 |
1626387-80-1 |
|
Granisetron
|
格拉司琼 |
109889-09-0 |
|
APR-246
|
PRIMA-1Met |
5291-32-7 |
|
Cyclohexyl(phenyl)methanol
|
环己基(苯基)甲醇 |
945-49-3 |
|
3-(p-Methoxyphenyl)-1,2,3,4-tetrahydronaphthalen-1-one
|
3-(4-甲氧基苯基)-1(2H)-萘酮 |
61696-79-5 |
|
Toremifene Citrate
|
枸橼酸托瑞米芬 |
89778-27-8 |
|
T9175;A51
|
|
2079068-74-7 |
|
Tadalafil intermediate 1
|
他达拉非中间体1 |
171752-68-4 |
|
Cabazitaxel intermediate
|
7,10二甲氧基10-DAB (卡巴他赛中间体) |
183133-94-0 |
|
Enclomiphene citrate
|
恩氯米芬柠檬酸盐 |
7599-79-3 |
|
Tadalafil intermediate 2
|
他达拉非中间体2 |
171489-59-1 |
|
|
化合物A86新品 |
2079069-01-3 |
|
BMS-986165(Deucravacitinib)
|
|
2866415-98-5 |
|
BLU-451(LNG451)
|
BLU-451(LNG451) |
2769954-39-2 |
|
BI-4142
|
BI-4142 |
2682003-36-5 |
|
Testolone
|
Testolone (RAD140) |
1182367-47-0 |
|
Mobocertinib succinate
|
琥珀酸莫博替尼 |
2389149-74-8 |
|
Irbinitinib
|
妥卡替尼 |
937263-43-9 |
|
Maropitant Citrate
|
枸橼酸马罗匹坦 |
359875-09-5 |
|
Zongertinib
|
宗尔替尼 |
2728667-27-2 |
|
Cabazitaxel
|
卡巴他赛 |
183133-96-2 |
|
Selpercatinib
|
塞尔帕替尼 |
2152628-33-4 |
|
Taletrectinib
|
他立替尼 |
1505515-69-4 |
|
cabozantinib
|
卡博替尼 |
849217-68-1 |
|
Mobocertinib
|
莫博替尼 |
1847461-43-1 |
|
TAS6417
|
TAS6417 |
1661854-97-2 |
|
Mitoxantrone
|
米托蒽醌 |
65271-80-9 |
|
Sunvozertinib
|
舒沃替尼 |
2370013-49-1 |
|
Mitoxantrone dihydrochloride
|
盐酸米托蒽醌 |
70476-82-3 |
|
Cabozantinib Malate
|
苹果酸卡博替尼 |
1140909-48-3 |
|
Tuxobertinib (BDTX-189)
|
|
2414572-47-5 |
|
Brigatinib
|
布格替尼 |
1197953-54-0 |
|
Rocuronium bromide
|
罗库溴铵 |
119302-91-9 |
|
Vecuronium intermediate 6
|
维库溴铵第六部 |
13522-16-2 |
|
Vecuronium
|
维库 |
50700-72-6 |
|
Pancuronium bromide
|
泮库溴铵 |
15500-66-0 |
|
Rocuronium impurity H
|
罗库溴铵杂质H |
1190105-67-9 |
|
Rocuronium impurity E
|
罗库溴铵杂质E |
1190105-65-7 |
|
Rocuronium intermediate 7
|
罗库溴铵第七部 |
119302-20-4 |
|
Rocuronium intermediate 8
|
罗库溴铵第八部 |
119302-24-8 |
|
Rocuronium impurity D
|
罗库溴铵杂质D |
1190105-63-5 |
|
Clomiphene Citrate
|
枸橼酸氯米芬 |
50-41-9 |
|
Docetaxel
|
多西他赛（无水） |
114977-28-5 |
|
Paclitaxel
|
紫杉醇 |
33069-62-4 |
|
Docetaxel
|
多西他赛(三水) |
148408-66-6 |
